NCT01760954View on ClinicalTrials.gov

Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

December 28, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

April 15, 2016

Conditions
Endometriosis
Interventions
DRUG

Elagolix

Elagolix tablets administered orally

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY